Hyposplenism

D3_HYPOSPLENISM

splenic disease: A disease involving the spleen.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D73.0 Cause of death: ICD-10 — D73.0 2 out of 7 registries used, show all original rules.	49
4. Check minimum number of events None	49
5. Include endpoints None	49
6. Filter based on genotype QC (FinnGen only)	49

Control definitions (FinnGen only)

Control exclude: D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D73
Name in latin: Hyposplenismus

NAME	D3_HYPOSPLENISM
CONTROL_EXCLUDE	D3_BLOODOTHER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D730
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D730
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hyposplenism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	277	148	127
Only index persons	251	138	113
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.01	0.00
Median age at first event (years)
Whole population	52.16	52.98	51.62
Only index persons	52.71	52.98	52.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	49	30	19
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	61.70	58.89	66.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

30.03

26.16

2.8

1.4

94.8

90.3

0.18

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

27.87

23.24

2.9

1.6

3.3

4.2

g/l

—

(3036489) Thrombin time

21.53

21.47

2.8

1.3

21.7

21.2

0.21

(40758558) Short blood count panel - Blood

12.18

16.08

24.2

6.0

—

(3000991) Gas panel - Venous blood

10.57

13.95

12.6

11.2

—

(3023520) Reticulocytes [#/volume] in Blood

10.21

13.56

16.3

3.9

99.6

73.9

e9/l

0.86

(42870588) Differential panel, method unspecified - Blood

130

12.24

13.41

19.9

4.7

—

(3030467) Casts [#/volume] in Urine by Automated count

103

7.75

11.43

4.7

2.7

0.6

0.4

e6/l

0.33

(3018095) Leukocytes [#/volume] in Urine

140

8.64

10.96

5.0

3.5

657.7

53.6

e6/l

0.45

(36304419) Bacteria [Presence] in Urine

104

6.99

10.39

4.7

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

7.55

9.76

1.8

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6.46

9.46

4.4

2.4

1.6

0.8

e6/l

—

(3002582) Erythrocytes [#/volume] in Urine

118

6.50

9.42

4.7

3.0

198.0

17.9

e6/l

0.51

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

129

5.77

8.20

4.7

2.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5.73

8.16

4.5

2.4

2.3

0.6

e6/l

—

(3012544) pH of Venous blood

6.50

8.14

11.4

5.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5.38

7.96

2.4

1.9

3.4

2.8

mg/l

0.40

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

9.17

7.89

2.7

1.1

0.0

g/l

0.00

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

9.17

7.89

2.7

1.1

0.0

g/l

0.00

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

8.58

7.48

2.7

1.1

0.0

g/l

0.00

(3013650) Neutrophils [#/volume] in Blood by Automated count

227

6.93

7.24

36.5

9.2

4.5

4.2

e9/l

0.31

195

(3042936) Bacteria identified in Isolate by Culture

5.34

7.23

3.5

3.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

7.01

7.21

17.1

14.3

10.0

10.5

mmol/l

0.08

(4035726)

5.61

6.69

1.9

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

109

4.66

6.65

5.7

3.4

289.4

8585.5

umol/l

1.06

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

7.18

6.42

2.7

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

7.60

6.22

4.9

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

100

4.41

6.18

12.2

2.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

6.80

6.12

8.3

12.3

91.9

94.2

0.37

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

162

4.59

5.98

2.5

1.9

98.0

92.0

pmol/l

0.30

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

18.68

5.62

1.8

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

128

4.10

5.57

13.7

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

13.41

5.54

1.3

2.4

—

(3023368) Bacteria identified in Blood by Culture

102

3.96

5.32

14.4

4.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

11.90

5.27

1.8

2.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3.99

5.27

1.9

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4.07

5.15

2.0

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

4.29

5.07

2.2

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

5.16

4.95

2.9

3.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3.72

4.72

2.0

1.7

2.9

g/l

0.93

(3001122) Ferritin [Mass/volume] in Serum or Plasma

173

3.78

4.66

13.1

2.6

352.7

87.9

ug/l

0.85

155

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5.45

4.53

10.4

4.8

24.3

25.0

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

186

3.70

4.41

13.5

4.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

4.64

4.39

9.9

3.0

5.3

5.0

kpa

0.10

(3019309) Folate [Moles/volume] in Red Blood Cells

3.68

4.37

1.8

1.5

659.9

1154.9

nmol/l

3.13

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

7.59

4.20

8.8

49.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.86

3.90

2.4

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4.44

3.89

8.3

25.3

104.8

126.7

g/l

1.83

(3011397) Hemoglobin [Presence] in Urine by Test strip

3.40

3.89

2.2

3.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

13.39

3.87

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

13.39

3.87

1.2

1.0

102.2

112.8

—

(4306422)

13.39

3.87

1.0

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

6.22

3.71

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

11.15

3.60

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.52

3.43

2.4

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

9.54

3.36

1.5

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5.00

3.17

2.6

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

8.34

3.15

1.2

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

8.34

3.15

1.2

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

8.34

3.15

6.3

13.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

10.92

3.04

2.0

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

10.92

3.04

1.0

94.8

102.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

7.40

2.96

1.7

1.2

—

(3024928) Oxygen saturation in Venous blood

7.40

2.96

10.5

5.2

—

(40768795) Lymph node Pathology biopsy report

9.09

2.81

1.2

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

9.09

2.81

1.6

1.8

—

(21494434) Karyotype in Bone marrow

9.09

2.81

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

9.09

2.81

1.0

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

6.65

2.78

1.8

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

6.04

2.62

1.0

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

7.78

2.61

2.0

1.3

—

(40768804) Tissue Pathology biopsy report

168

2.56

2.59

3.6

2.0

—

(3002256) Pathology report gross observation

3.13

2.58

2.2

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.61

2.46

1.7

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

6.80

2.43

1.6

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

6.80

2.43

11.0

2.8

55.4

63.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

280

2.92

2.42

4.6

4.0

—

(40768797) Stomach Pathology biopsy report

2.86

2.36

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

5.09

2.35

1.2

—

(3012516) Albumin [Mass/volume] in Urine

115

2.45

2.30

3.7

2.9

88.1

108.8

mg/l

0.09

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

6.04

2.27

2.0

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

6.04

2.27

2.0

1.4

—

(3003396) Base excess in Arterial blood by calculation

2.93

2.19

8.4

17.9

-2.0

1.3

mmol/l

1.23

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.90

2.14

8.1

3.0

1.0

0.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

5.42

2.12

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

5.42

2.12

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

5.42

2.12

1.0

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

4.40

2.11

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

4.92

1.99

1.0

1.4

—

(3044889) 12 lead EKG panel

262

2.41

1.95

5.2

3.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

262

2.41

1.95

5.7

3.0

49.0

48.4

u/l

0.02

244

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.40

1.89

2.6

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.67

1.86

1.8

2.1

—

(3000492) Spirometry study

2.98

1.82

1.8

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

277

2.37

1.81

5.9

4.4

—

432.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

4.15

1.76

2.0

2.4

—

(3037756) Immunofixation for Serum or Plasma

4.15

1.76

2.2

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

119

2.15

1.73

4.2

3.4

23.2

16.6

mg/mmol

0.16

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.09

1.72

2.4

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3.27

1.63

9.3

3.0

0.9

1.3

—

(4010399)

2.53

1.50

1.3

—

(3000494) Fungus identified in Specimen by Culture

2.42

1.45

1.8

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.00

1.40

0.0

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.15

1.39

1.4

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.81

1.24

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.25

1.22

1.5

1.7

—

(3015736) pH of Urine

151

1.83

1.19

2.1

3.4

—

(1761868) Lipid panel - Serum or Plasma

140

0.49

1.04

3.1

2.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.10

1.02

4.4

2.9

—

(3003694) ABO and Rh group [Type] in Blood

106

1.76

0.94

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

124

1.71

0.93

3.7

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.80

0.89

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.91

0.87

1.1

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

383

2.00

0.85

5.3

4.5

5.8

5.9

mmol/l

0.19

349

(3019060) Gas panel - Arterial blood

0.00

0.81

0.0

21.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.80

0.0

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

122

1.60

0.73

1.3

2.1

111.0

181.9

u/l

0.61

113

(3013512) EKG study

100

0.54

0.72

6.2

4.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.62

0.0

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.65

0.52

1.3

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

397

1.68

0.48

53.8

13.6

29.3

25.1

mg/l

0.39

297

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

280

1.41

0.47

3.9

2.9

—

(4034850)

0.00

0.42

0.0

16.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

357

1.45

0.40

7.9

5.3

39.5

mmol/mol

0.00

337

(3022145) Colonoscopy Study observation

1.35

0.24

1.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

101

0.75

0.24

2.3

3.4

—

(36660697) Celiac disease serology panel - Serum

1.24

0.23

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

0.00

0.21

0.0

51.1

—

0.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

0.00

0.21

0.0

51.1

—

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1.31

0.21

35.0

24.9

—

1.3

—

(3020891) Body temperature

0.00

0.21

0.0

5.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.15

0.09

1.7

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.87

0.07

8.0

5.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

131

0.89

0.06

1.9

3.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.00

0.00

1.2

2.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.0

3.3

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.0

8.7

—

29.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

5.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.04

0.00

1.5

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

12.8

—

(3039000) Anion gap in Blood

0.00

0.0

83.3

—

12.0

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3018572) Chloride [Moles/volume] in Blood

0.00

0.0

83.3

—

105.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_HYPOSPLENISM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_HYPOSPLENISM.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: D3_HYPOSPLENISM – Hyposplenism

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hyposplenism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints